Progenics And Wyeth Announce FDA Has Approved Relistor
Progenics And Wyeth Announce FDA Has Approved Relistor
|
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. |
read more...
News entry number 4484 added on Apr 28, 2008 in the Health category.
Comenteaza
Other News in the Health category
Categorie:
Categorie:
Categorie:
Categorie:
Categorie:
Related Links
- ZymoGenetics Announces FDA Approval Of RECOTHROMTM 20,000-IU Vial Size And Co-Packaging With
- Halifax 32 Whitehaven 24: Holroyd has Fax on-message
- Maple Leaf Jason Blake has rare leukemia
- How Clinton has built her lead
- Education has a champion in Somalia
- Racing: Jewell's crowning glory Rowe Park has Abbaye aim
- Tamer of Troubled Schools Has Plan in New Orleans
- Saban Has Alabama Back in AP Top 25 Poll
- UCLA has plenty to gain against Utah
News Categories
745
522
479
347
1003
691
279
973
Top 10 News
- Texas Woman Claims to Have Found Mythical 'Chupacabra'
- Wireless technology hits security budgets
- Google Starts Hosting News on Website
- Study Focuses On Cancer Risk In Biologic Treatment For Rheumatoid Arthritis
- Google forced to push image in China
- Ho-hum, the guest's another candidate
- Microsoft purchase of RIM nice to consider, but unlikely
- Western School Board limits digital devices
- 'Spooky' science points to quantum internet
- Nuñez, gov. gamble on healthcare overhaul
Statistics
News:
News Categories:
News Read:
News Categories:
News Read:
5039
8
620
8
620